NexImmune to Present at the 2021 Barclays Global Healthcare Conference

Rhea-AI Summary

NexImmune, Inc. (Nasdaq: NEXI), a clinical-stage biotechnology company, announced that CEO Scott Carmer will present a company overview at the virtual 2021 Barclays Global Healthcare Conference on March 11, 2021, at 10:55 a.m. Eastern time.

The presentation will be available via live webcast, and a replay will be accessible on the NexImmune website post-event. The company focuses on developing innovative immunotherapy designed to direct antigen-specific T cells for a targeted immune response, promoting a potent and durable reaction mimicking natural biology.

GAITHERSBURG, Md., March 02, 2021 (GLOBE NEWSWIRE) -- NexImmune, Inc. (Nasdaq: NEXI), a clinical-stage biotechnology company developing a novel approach to immunotherapy designed to orchestrate a targeted immune response by directing the function of antigen-specific T cells, today announced that Scott Carmer, Chief Executive Officer, will present a company overview at the virtual 2021 Barclays Global Healthcare Conference on Thursday, March 11, 2021 at 10:55 a.m. Eastern time.

The presentation will be accessible via live webcast by visiting https://ir.neximmune.com/investors/events-and-presentations. A replay will be available on the NexImmune website following the presentation.

About NexImmune

NexImmune, based in Gaithersburg, Maryland, is a clinical-stage biotechnology company developing a novel approach to immunotherapy designed to orchestrate a targeted immune response by directing the function of antigen-specific T cells to generate a specific, potent and durable immune response that mimics natural biology. For more information, visit www.neximmune.com.

Contacts

Investors:
Chad Rubin
Solebury Trout
646-378-2947
crubin@soleburytrout.com 

Media:
Mike Beyer
Sam Brown Inc. Healthcare Communications
312-961-2502
mikebeyer@sambrown.com 

FAQ

When is Scott Carmer's presentation for NexImmune at the Barclays Global Healthcare Conference?

Scott Carmer's presentation for NexImmune is scheduled for March 11, 2021, at 10:55 a.m. Eastern time.

Where can I watch the NexImmune presentation at the Barclays Global Healthcare Conference?

You can watch the NexImmune presentation via live webcast on their investor events page.

What is the focus of NexImmune's immunotherapy approach?

NexImmune focuses on developing a novel immunotherapy to direct antigen-specific T cells for a targeted immune response.

What company ticker symbol represents NexImmune?

The ticker symbol for NexImmune is NEXI.

Is there a replay available for NexImmune's presentation at the Barclays Conference?

Yes, a replay of NexImmune's presentation will be available on their website after the event.